NBD AI Bulletin，Apeloa Pharmaceutical Co., Ltd. (the Company, SZ 000739, closing price: 21.5 yuan) announced on the evening of June 10 that the lock-up period for the Company's first employee shareholding plan had expired. The employee shareholding plan involves about 32.66 million shares of the Company transfered from holders at an average price of 7.98 yuan per share on June 11, 2019, accounting for 2.77% of the company's total share capital.
According to the 2019 annual report, Apeloa Pharmaceutical Co., Ltd.'s main business is the pharmaceutical industry, accounting for 99.83% of revenue.
Apeloa Pharmaceutical Co., Ltd.'s chairman is Zhu Fangmeng, male, 48 years old, master's degree, senior engineer, EMBA from China Europe International Business School. Apeloa Pharmaceutical Co., Ltd.'s general manager is Xu Xinliang, male, 51, bachelor's degree, and a senior engineer.
(By Li Menglin)
Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.